logo
Select company
Select metric
$ -0.16EBITDA per Share
VS
Market
30
Sector
70
Industry
40
History
93
$ 2.75Close
$ 0.73 - $ 3.83 52-Week Range
Ticker Information

Ticker

ESPR

Company Name

ESPERION THERAPEUTICS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

ESPERION THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ESPR - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -32.49M$ -0.161197.55M
3/31/2025$ -88.47M$ -0.451196.13M
12/31/2024$ 7.57M$ 0.041187.18M
9/30/2024$ -28.84M$ -0.151194.93M
6/30/2024$ -40.66M$ -0.221188.79M
3/31/2024$ -27.81M$ -0.161169.26M
12/31/2023$ -150.11M$ -1.461103.11M
9/30/2023$ -149.89M$ -1.341111.87M
6/30/2023$ -164.52M$ -1.511109.24M
3/31/2023$ -181.08M$ -2.31178.44M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ESPERION THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -2.97.
  • Over the past 5 years, ESPERION THERAPEUTICS INC's average EBITDAPS has been $ -3.02.
  • The median EBITDAPS for ESPERION THERAPEUTICS INC during this period was $ -2.48
  • ESPERION THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ 0.04.
  • The lowest EBITDAPS recorded by ESPERION THERAPEUTICS INC in the same timeframe $ -11.09

ESPERION THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
ACB : AURORA CANNABIS INC $ 0.01CGC : CANOPY GROWTH CORP $ -1.82EOLS : EVOLUS INC $ -0.52SIGA : SIGA TECHNOLOGIES INC $ 1.51RIGL : RIGEL PHARMACEUTICALS INC $ 6.11LFCR : LIFECORE BIOMEDICAL INC $ -0.25IRWD : IRONWOOD PHARMACEUTICALS INC $ 0.5ETON : ETON PHARMACEUTICALS INC $ 0.07OGI : ORGANIGRAM GLOBAL INC $ 0.08AQST : AQUESTIVE THERAPEUTICS INC $ -0.48

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for ESPERION THERAPEUTICS INC is calculated as follows: EBITDA [ $ -82.67M ] / (Shares WA [ 27.83M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -2.97 ]

ESPR - EBITDA per Share, Last 5 years

$ -11.09

Minimum

Jun 30, 2021

$ 0.04

Maximum

Dec 31, 2024

$ -3.02

Average

$ -2.48

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26